Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07455201 · ClinicalTrials.gov registry record · NA
Evaluating a Prototype CT Scan for ICH Evacuation
A NA study of Intracerebral Hemorrhage, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07455201: Recruiting NA study of Intracerebral Hemorrhage, sponsored by Icahn School of Medicine at Mount Sinai.
NCT07455201 is a NA study of Intracerebral Hemorrhage that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 15 participants, below the 1,105-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07455201, a NA study of Intracerebral Hemorrhage, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the project is to collect pre-procedural CT scans, intra-procedural post-evacuation scans as well as immediate post-procedural CT scans to evaluate and collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic hemorrhage detection prototype. The assessment of the prototypes, including its features will focus on the feasibility, usefulness as well as the potential clinical value add in minimally invasive ICH treatment.
Primary Outcome
Quantitative assessment of the comparison of the detected residual hemorrhage on the DynaCT Sine Spin data and the detected residual hematoma on the immediate post-procedural CT
Conditions Studied
Interventions
- DEVICE DynaCT Multiphase
- DEVICE DynaCT Sine Spin
Study Locations (1)
New York
- Mount Sinai West - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-10-31 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT07455201 shows while recruiting
NCT07455201 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,105-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which DynaCT Multiphase is the first listed.
NCT07455201 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07455201 about?
NCT07455201 is a clinical study titled "Evaluating a Prototype CT Scan for ICH Evacuation". The aim of the project is to collect pre-procedural CT scans, intra-procedural post-evacuation scans as well as immediate post-procedural CT scans to evaluate and collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic hemorrhage detection prototype. The assessment of the...
What is the current status of trial NCT07455201?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-10-31. Estimated completion is 2028-12-31.
What conditions does trial NCT07455201 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage.
What interventions are being tested in trial NCT07455201?
The interventions under investigation include: DynaCT Multiphase (DEVICE), DynaCT Sine Spin (DEVICE).
Who is sponsoring clinical trial NCT07455201?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07455201 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07455201's enrollment target sits among peer trials
15 31st of 31 higher than 1 of 31 other Intracerebral Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracerebral Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Auricular VNS Following Intracerebral Hemorrhage
RECRUITING · NA
-
Short-term And Longer-term Cognitive Impact Of Neurochecks
RECRUITING · NA
-
Implementation of Neuro Lung Protective Ventilation
ACTIVE NOT RECRUITING · NA
-
Stroke and CPAP Outcome Study 3
COMPLETED · NA
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI